| Code |
Product Description |
Specification |
Material |
| 74907503 |
Extraosseous Talotarsal Stabilization Ⅲ |
5.0x18.5 |
T |
| 74907553 |
Extraosseous Talotarsal Stabilization Ⅲ |
5.5x18.5 |
T |
| 74907603 |
Extraosseous Talotarsal Stabilization Ⅲ |
6.0x18.5 |
T |
| 74907653 |
Extraosseous Talotarsal Stabilization Ⅲ |
6.5x18.5 |
T |
| 74907703 |
Extraosseous Talotarsal Stabilization Ⅲ |
7.0x18.5 |
T |
| 74907753 |
Extraosseous Talotarsal Stabilization Ⅲ |
7.5x18.5 |
T |
| 74907803 |
Extraosseous Talotarsal Stabilization Ⅲ |
8.0x18.5 |
T |
| 74907853 |
Extraosseous Talotarsal Stabilization Ⅲ |
8.5x18.5 |
T |
| 74907903 |
Extraosseous Talotarsal Stabilization Ⅲ |
9.0x18.5 |
T |
| 74907953 |
Extraosseous Talotarsal Stabilization Ⅲ |
9.5x18.5 |
T |
| 74907103 |
Extraosseous Talotarsal Stabilization Ⅲ |
10.0x18.5 |
T |
| 74907113 |
Extraosseous Talotarsal Stabilization Ⅲ |
11.0x18.5 |
T |
The CareFix Subtalar Joint Stabilizer (Extraosseous Talotarsal Stabilization) is manufactured from medical-grade titanium alloy and available in Type I, II, and III structural configurations. Designed to stabilize the subtalar joint for treating flatfoot, posterior heel valgus deformities, and subtalar joint dislocation/instability, this implant provides targeted correction while preserving joint function.
Flexible flatfoot (pediatric, adolescent, or adult).
Flatfoot with navicular bone disorders.
Spastic or paralytic flatfoot (e.g., posterior tibial tendon dysfunction).
Posterior heel valgus deformities.
Subtalar joint dislocation or instability.
Local soft tissue damage or defects (insufficient tissue coverage at the implantation site).
Active or mixed infections at the surgical site.
Poor bone quality (osteoporosis, osteopenia, malignant tumors) compromising fixation.
Rigid flatfoot, vertical talus, subtalar/tarsal arthritis, or clubfoot deformities.
Hypersensitivity to implant materials.
Immunosuppressive disorders, severe hepatic/renal dysfunction, or uncontrolled diabetes.
Systemic psychiatric conditions.
Patient noncompliance with activity restrictions or postoperative care.
Children under 4 years old, elderly patients, or pregnant/breastfeeding women.
Titanium alloy biocompatibility: High strength, corrosion resistance, and long-term implant safety.
Minimally invasive procedure: Requires only a 1-3 cm incision, reducing tissue trauma.
Biomechanical correction: Restores natural hindfoot motion while preserving joint integrity for potential revision surgeries.
Self-contained design: No additional instruments or bone grafts required for implantation.
EN
